QBIO - Q Biomed Stock Price, News & Analysis

$4.40 0.14 (3.29 %)
(As of 11/23/2017 04:00 PM ET)
Previous Close$4.40
Today's Range$4.40 - $4.26
52-Week Range$3.04 - $12.61
Volume134,331 shs
Average Volume66,115 shs
Market Capitalization$49.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69

About Q Biomed (OTCMKTS:QBIO)

Q Biomed logoQ BioMed, Inc., formerly ISMO Tech Solutions, Inc., is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors. The Company intends to develop these assets to provide returns through organic growth, out-licensing, sale or spin-off into new public companies. The Company holds license for a generic drug, Strontium Chloride (SR89). SR89 is a radiopharmaceutical agent and indicated for the treatment of pain associated with metastatic bone cancer. Its asset, MAN-01, is indicated for the treatment of glaucoma. MAN-01 is in pre-clinical stage. The Company is assessing multiple biomedical assets in various areas of healthcare and drug development. It is pursuing a pipeline of therapeutics, diagnostics and orphan drug candidates.


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:QBIO
  • Previous Symbol: NASDAQ:QBIO
  • CUSIPN/A

    Debt

    Debt-to-Equity RatioN/A
    Current Ratio1.00%
    Quick Ratio1.00%

    Price-To-Earnings

    Trailing P/E RatioN/A
    Forward P/E RatioN/A
    P/E GrowthN/A

    Sales & Book Value

    Annual SalesN/A
    Price / SalesN/A
    Cash FlowN/A
    Price / CashN/A
    Book Value($0.22) per share
    Price / Book-20.00

    Dividend

    Annual DividendN/A
    Dividend YieldN/A

    Profitability

    Trailing EPSN/A
    Net Income$-7,170,000.00
    Net MarginsN/A
    Return on EquityN/A
    Return on Assets-893.92%

    Miscellaneous

    EmployeesN/A
    Outstanding Shares11,690,000

    Frequently Asked Questions for Q Biomed (OTCMKTS:QBIO)

    What is Q Biomed's stock symbol?

    Q Biomed trades on the OTCMKTS under the ticker symbol "QBIO."

    When will Q Biomed make its next earnings announcement?

    Q Biomed is scheduled to release their next quarterly earnings announcement on Monday, November, 27th 2017. View Earnings Estimates for Q Biomed.

    Who are some of Q Biomed's key competitors?

    How do I buy Q Biomed stock?

    Shares of Q Biomed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is Q Biomed's stock price today?

    One share of Q Biomed stock can currently be purchased for approximately $4.40.

    How big of a company is Q Biomed?

    Q Biomed has a market capitalization of $49.82 million.

    How can I contact Q Biomed?

    Q Biomed's mailing address is 501 MADISON AVENUE 14TH FLOOR, NEW YORK NY, 10022. The company can be reached via phone at 212-588-0022.


    MarketBeat Community Rating for Q Biomed (QBIO)

    Community Ranking:  2.2 out of 5 (star star)
    Outperform Votes:  26 (Vote Outperform)
    Underperform Votes:  34 (Vote Underperform)
    Total Votes:  60
    MarketBeat's community ratings are surveys of what our community members think about Q Biomed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for Q Biomed (OTCMKTS:QBIO)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
    Consensus Rating:N/A (Score: NaN)
    Analysts' Consensus Price Target: N/A

    Consensus Price Target History for Q Biomed (OTCMKTS:QBIO)

    Price Target History for Q Biomed (OTCMKTS:QBIO)

    Analysts' Ratings History for Q Biomed (OTCMKTS:QBIO)

    Show:
    No equities research coverage for this company has been tracked by MarketBeat.com

    Earnings

    Earnings History for Q Biomed (OTCMKTS:QBIO)


    No earnings announcements for this company have been tracked by MarketBeat.com

    Estimates

    Earnings Estimates for Q Biomed (OTCMKTS:QBIO)

    No earnings estimates for this company have been tracked by MarketBeat.com

    Dividends

    Dividend History for Q Biomed (OTCMKTS:QBIO)
    No dividend announcements for this company have been tracked by MarketBeat.com

    Insider Trades

    Insider Trading and Institutional Ownership History for Q Biomed (OTCMKTS QBIO)

    Institutional Ownership Percentage: 0.01%
    Insider Trades by Quarter for Q Biomed (OTCMKTS:QBIO)

    Insider Trades by Quarter for Q Biomed (OTCMKTS QBIO)

    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    3/28/2017William S RosenstadtGeneral CounselSell55,051$4.10$225,709.10View SEC Filing  
    (Data available from 1/1/2013 forward)

    Headlines

    Latest Headlines for Q Biomed (OTCMKTS QBIO)

    Source:

    Social Media

    Financials

    Chart

    Q Biomed (OTCMKTS QBIO) Chart for Thursday, November, 23, 2017
    Loading chart…

    This page was last updated on 11/23/2017 by MarketBeat.com Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.